high resolution ms vs triple quadrupole · 2018-06-04 · confidential 11 +ms2 (971.80): 10 mca...

15
Confidential High resolution MS vs Triple Quadrupole Why aren’t we all using it? Johannes Stanta PhD Method Development Manager November 2014

Upload: others

Post on 26-Jan-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Confidential

High resolution MS vs Triple Quadrupole Why aren’t we all using it?

Johannes Stanta PhD Method Development Manager November 2014

Confidential

High Resolution benefits •  Full scan data

•  Quantitative and qualitative data

•  Retrospective integration and analysis

•  Minimal method development

•  No optimisation between MS

•  Selectivity

•  Discrimination of multi-charge analytes

•  Co-elution of tryptic digested peptides

•  Eliminating matrix effects and “dirty extracts”

•  Large dynamic range

•  Remove chromatography

Confidential

High resolution MS

•  Sensitivity •  Instrumentation cost •  Regulatory acceptance? •  Data volume

Perceived shortfalls

Confidential

Triple Quad MS

•  Long development times •  Dedicated skilled analyst •  Matrix interference with similar m/z •  Cross talk / cross ion •  Metabolites with close m/z

Perceived shortfalls

Confidential

Why are we not all using it? Review of published methods 2012 – 2014

1 published method Analyte / Species

Range Author

Aesculin in rat

10/50 – 1500 ng/mL (no LLOQ QC)

Yi Li et al 2013 (Xi'an Jiaotong University)

HRMS

TQ-MS 64 published methods

Confidential

Our experience

Analyte MW (Da)

QTOF range (ng/mL)

TQ range (ng/mL)

Clobetasol 467 10 – 500 0.01 – 10 Clobetasol propionate 411 5 – 500 0.01 – 10

oligonucleotide 18-mer 5825 50 – ? 1 – 500

Insulin glargine 6063 20 – ? 0.2 – 200 0.05 – 10

Confidential

Case study: Difficult and sensitive high throughput assay

Protein analysis on TQ – breaking the 50 pg/mL barrier for insulin analysis

Confidential

Glargine Lispro Aspart

Confidential

Confidential

10

+Q1: 20 MCA scans from Sample 1 (TuneSampleID) of MT20140717124544.wiff (Turbo Spray) Max. 2.4e8 cps.

700 750 800 850 900 950 1000 1050 1100 1150 1200 1250m/z, Da

0.0

1.0e7

2.0e7

3.0e7

4.0e7

5.0e7

6.0e7

7.0e7

8.0e7

9.0e7

1.0e8

1.1e8

1.2e8

1.3e8

1.4e8

1.5e8

1.6e8

1.7e8

1.8e8

1.9e8

2.0e8

2.1e8

2.2e8

2.3e8

2.4e8

Inte

nsi

ty,

cps

866.9

968.6

971.7

956.4

1162.41011.2 1147.4

758.7

979.2

966.8875.8

1021.6

1174.6992.4

1159.9828.9977.3839.4766.5 819.9 1031.8884.8

1003.0 1213.1988.3 1027.6897.3 944.5833.0 1190.71172.41038.11013.4785.5 870.0850.6763.7 913.5890.1 1225.81065.6 1203.4953.4 1016.5 1133.1756.6 962.4827.5 946.5707.4 1073.4 1182.5712.7 790.6770.8 1086.5 1139.5 1247.8

Glargine [M+8H]8+

Glargine [M+7H]7+

Glargine [M+6H]6+

Glargine [M+5H]5+

Lispro [M+6H]6+

Lispro [M+5H]5+

Aspart [M+6H]6+

Aspart [M+6H]6+

Bovine [M+6H]6+

Bovine [M+6H]6+

+Q1: 20 MCA scans from Sample 1 (TuneSampleID) of MT20140717124544.wiff (Turbo Spray) Max. 2.4e8 cps.

700 750 800 850 900 950 1000 1050 1100 1150 1200 1250m/z, Da

0.0

1.0e7

2.0e7

3.0e7

4.0e7

5.0e7

6.0e7

7.0e7

8.0e7

9.0e7

1.0e8

1.1e8

1.2e8

1.3e8

1.4e8

1.5e8

1.6e8

1.7e8

1.8e8

1.9e8

2.0e8

2.1e8

2.2e8

2.3e8

2.4e8

Inte

nsi

ty,

cps

866.9

968.6

971.7

956.4

1162.41011.2 1147.4

758.7

979.2

966.8875.8

1021.6

1174.6992.4

1159.9828.9977.3839.4766.5 819.9 1031.8884.8

1003.0 1213.1988.3 1027.6897.3 944.5833.0 1190.71172.41038.11013.4785.5 870.0850.6763.7 913.5890.1 1225.81065.6 1203.4953.4 1016.5 1133.1756.6 962.4827.5 946.5707.4 1073.4 1182.5712.7 790.6770.8 1086.5 1139.5 1247.8

Glargine [M+8H]8+

Glargine [M+7H]7+

Glargine [M+6H]6+

Glargine [M+5H]5+

Lispro [M+6H]6+

Lispro [M+5H]5+

Aspart [M+6H]6+

Aspart [M+6H]6+

Bovine [M+6H]6+

Bovine [M+6H]6+

Confidential

11

+MS2 (971.80): 10 MCA scans from Sample 1 (TuneSampleID) of MT20140717140308.wiff (Turbo Spray) Max. 8.3e6 cps.

100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100 1150 1200 1250m/z, Da

0.0

5.0e5

1.0e6

1.5e6

2.0e6

2.5e6

3.0e6

3.5e6

4.0e6

4.5e6

5.0e6

5.5e6

6.0e6

6.5e6

7.0e6

7.5e6

8.0e68.3e6

Inte

nsi

ty,

cps

971.7

136.0

660.9

464.21133.3

627.31139.5

968.6

1110.4952.7 1123.5

119.9 132.9893.9219.2 925.6774.4 1073.5 1129.5314.2 1226.7363.1248.1 1017.1226.1143.1 856.1387.8 829.0 1081.7632.4 940.0345.2 1184.3283.2 651.8446.2181.0 712.2 1172.9878.4609.2 1023.1839.8201.0 508.3378.9 399.1

‘Sensitive’ product ion (tyrosine immonium ion)

Unfragmented precursor

‘Selective’product ion

+MS2 (971.80): 10 MCA scans from Sample 1 (TuneSampleID) of MT20140717140308.wiff (Turbo Spray) Max. 8.3e6 cps.

100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100 1150 1200 1250m/z, Da

0.0

5.0e5

1.0e6

1.5e6

2.0e6

2.5e6

3.0e6

3.5e6

4.0e6

4.5e6

5.0e6

5.5e6

6.0e6

6.5e6

7.0e6

7.5e6

8.0e68.3e6

Inte

nsi

ty,

cps

971.7

136.0

660.9

464.21133.3

627.31139.5

968.6

1110.4952.7 1123.5

119.9 132.9893.9219.2 925.6774.4 1073.5 1129.5314.2 1226.7363.1248.1 1017.1226.1143.1 856.1387.8 829.0 1081.7632.4 940.0345.2 1184.3283.2 651.8446.2181.0 712.2 1172.9878.4609.2 1023.1839.8201.0 508.3378.9 399.1

‘Sensitive’ product ion (tyrosine immonium ion)

Unfragmented precursor

‘Selective’product ion

Confidential

Time  (min)

Glargine  (‘Selective’)200  pg/mL

Bovine  (ISTD)

Lispro  50  pg/mL Bovine  (ISTD)

Bovine  (ISTD)Aspart  (‘Selective’)100  pg/mL

Time  (min)

Glargine  (‘Selective’)200  pg/mL

Bovine  (ISTD)

Lispro  50  pg/mL Bovine  (ISTD)

Bovine  (ISTD)Aspart  (‘Selective’)100  pg/mL

Confidential

Glargine  (‘Sensitive’)50  pg/mL

Bovine  (ISTD)

Lispro  50  pg/mL

Aspart  (‘Sensitive’)50  pg/mL

Time  (min)

Bovine  (ISTD)

Bovine  (ISTD)

Glargine  (‘Sensitive’)50  pg/mL

Bovine  (ISTD)

Lispro  50  pg/mL

Aspart  (‘Sensitive’)50  pg/mL

Time  (min)

Bovine  (ISTD)

Bovine  (ISTD)

Confidential

Triple Quadrupole – accelerating in sensitivity

Microsampling Selectivity solutions

•  Selective extraction •  SelexION

Confidential

Conclusion

High resolution •  Data advantage •  Needs to be more sensitive Triple Quadrupole •  Unbeaten for regulated bioanalysis •  Technological developments to overcome

shortfalls